Company profile

Kiniksa Pharmaceuticals International, plc insider acquisitions

Company CIK 0001730430 · Reported insider acquisitions and filing context.

Company filings at SEC ↗
KNSA · Nasdaq

These are company listings. A transaction is linked to a particular security only when the filing provides enough information.

Company activity summary

By transaction date, as of October 23, 2026.

7 days30 days90 daysOverlapping periods · securities and currencies kept separate

No records are loaded for this 30-day transaction window. This does not establish that no transactions occurred.

Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Tessari EbenTessari EbenQuart Barry DQuart Barry DRagosa MarkRagosa MarkPatel Sanj KPatel Sanj KPaolini John F.Paolini John F.Megna Michael RMegna Michael RTessari Eben · December 15, 2025 · Exercise / conversion · Class A Ordinary ShareQuart Barry D · December 15, 2025 · Exercise / conversion · Class A Ordinary ShareRagosa Mark · December 8, 2025 · Exercise / conversion · Class A Ordinary ShareRagosa Mark · December 8, 2025 · Exercise / conversion · Class A Ordinary ShareRagosa Mark · December 8, 2025 · Exercise / conversion · Class A Ordinary ShareTessari Eben · November 26, 2025 · Exercise / conversion · Class A Ordinary ShareTessari Eben · November 17, 2025 · Exercise / conversion · Class A Ordinary ShareRagosa Mark · November 12, 2025 · Exercise / conversion · Class A Ordinary SharePatel Sanj K · November 13, 2025 · Gift received · Class A Ordinary SharePatel Sanj K · November 12, 2025 · Gift received · Class A Ordinary SharePaolini John F. · October 31, 2025 · Exercise / conversion · Class A Ordinary SharePaolini John F. · October 31, 2025 · Exercise / conversion · Class A Ordinary ShareRagosa Mark · October 28, 2025 · Exercise / conversion · Class A Ordinary SharePatel Sanj K · October 22, 2025 · Exercise / conversion · Class A Ordinary SharePatel Sanj K · October 21, 2025 · Exercise / conversion · Class A Ordinary SharePatel Sanj K · October 20, 2025 · Exercise / conversion · Class A Ordinary ShareMegna Michael R · October 20, 2025 · Exercise / conversion · Class A Ordinary ShareMegna Michael R · October 20, 2025 · Exercise / conversion · Class A Ordinary ShareMegna Michael R · October 20, 2025 · Exercise / conversion · Class A Ordinary ShareMegna Michael R · October 20, 2025 · Exercise / conversion · Class A Ordinary ShareMegna Michael R · October 20, 2025 · Exercise / conversion · Class A Ordinary ShareTessari Eben · October 14, 2025 · Exercise / conversion · Class A Ordinary ShareOct 14, 2025Dec 15, 2025
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

22 dated transactions · 6 of 6 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Dec 15, 2025Kiniksa Pharmaceuticals International, plcClass A Ordinary ShareTessari EbenExercise / conversion
Dec 15, 2025Kiniksa Pharmaceuticals International, plcClass A Ordinary ShareQuart Barry DExercise / conversion
Dec 8, 2025Kiniksa Pharmaceuticals International, plcClass A Ordinary ShareRagosa MarkExercise / conversion
Dec 8, 2025Kiniksa Pharmaceuticals International, plcClass A Ordinary ShareRagosa MarkExercise / conversion
Dec 8, 2025Kiniksa Pharmaceuticals International, plcClass A Ordinary ShareRagosa MarkExercise / conversion
Nov 26, 2025Kiniksa Pharmaceuticals International, plcClass A Ordinary ShareTessari EbenExercise / conversion
Nov 17, 2025Kiniksa Pharmaceuticals International, plcClass A Ordinary ShareTessari EbenExercise / conversion
Nov 12, 2025Kiniksa Pharmaceuticals International, plcClass A Ordinary ShareRagosa MarkExercise / conversion
Nov 13, 2025Kiniksa Pharmaceuticals International, plcClass A Ordinary SharePatel Sanj KGift received
Nov 12, 2025Kiniksa Pharmaceuticals International, plcClass A Ordinary SharePatel Sanj KGift received
Oct 31, 2025Kiniksa Pharmaceuticals International, plcClass A Ordinary SharePaolini John F.Exercise / conversion
Oct 31, 2025Kiniksa Pharmaceuticals International, plcClass A Ordinary SharePaolini John F.Exercise / conversion
Oct 28, 2025Kiniksa Pharmaceuticals International, plcClass A Ordinary ShareRagosa MarkExercise / conversion
Oct 22, 2025Kiniksa Pharmaceuticals International, plcClass A Ordinary SharePatel Sanj KExercise / conversion
Oct 21, 2025Kiniksa Pharmaceuticals International, plcClass A Ordinary SharePatel Sanj KExercise / conversion
Oct 20, 2025Kiniksa Pharmaceuticals International, plcClass A Ordinary SharePatel Sanj KExercise / conversion
Oct 20, 2025Kiniksa Pharmaceuticals International, plcClass A Ordinary ShareMegna Michael RExercise / conversion
Oct 20, 2025Kiniksa Pharmaceuticals International, plcClass A Ordinary ShareMegna Michael RExercise / conversion
Oct 20, 2025Kiniksa Pharmaceuticals International, plcClass A Ordinary ShareMegna Michael RExercise / conversion
Oct 20, 2025Kiniksa Pharmaceuticals International, plcClass A Ordinary ShareMegna Michael RExercise / conversion
Oct 20, 2025Kiniksa Pharmaceuticals International, plcClass A Ordinary ShareMegna Michael RExercise / conversion
Oct 14, 2025Kiniksa Pharmaceuticals International, plcClass A Ordinary ShareTessari EbenExercise / conversion

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Share price & reported acquisitions

Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.

Price history is not available

Market-price history is not connected yet.

KNSA · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.

Reported acquisitions

Filing-date filters apply to the list and timeline. The summary above uses transaction dates.

Reset
Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedReporting ownersType / securityQuantityPrice / reference valueDetails
Trade:
Tessari EbenCHIEF OPERATING OFFICER
Exercise / conversionClass A Ordinary ShareNon-derivative security · Code M6,0008.83Value: 52,980Currency not specifiedView ↗
Trade: Exercise / conversionClass A Ordinary ShareNon-derivative security · Code M20,12910.36Value: 208,536.44Currency not specifiedView ↗
Trade:
Ragosa MarkCHIEF FINANCIAL OFFICER
Exercise / conversionClass A Ordinary ShareNon-derivative security · Code M10,51210.76Value: 113,109.12Currency not specifiedView ↗
Trade:
Ragosa MarkCHIEF FINANCIAL OFFICER
Exercise / conversionClass A Ordinary ShareNon-derivative security · Code M16,16511.97Value: 193,495.05Currency not specifiedView ↗
Trade:
Ragosa MarkCHIEF FINANCIAL OFFICER
Exercise / conversionClass A Ordinary ShareNon-derivative security · Code M16,16411.1Value: 179,420.4Currency not specifiedView ↗
Trade:
Tessari EbenCHIEF OPERATING OFFICER
Exercise / conversionClass A Ordinary ShareNon-derivative security · Code M20022.89Value: 4,578Currency not specifiedView ↗
Trade:
Tessari EbenCHIEF OPERATING OFFICER
Exercise / conversionClass A Ordinary ShareNon-derivative security · Code M6,5008.83Value: 57,395Currency not specifiedView ↗
Trade:
Ragosa MarkCHIEF FINANCIAL OFFICER
Exercise / conversionClass A Ordinary ShareNon-derivative security · Code M19,90030.93Value: 615,507Currency not specifiedView ↗
Trade:
Patel Sanj KCHAIRMAN & CEO · Director
Gift receivedClass A Ordinary ShareNon-derivative security · Code G60,0000Value: 0Currency not specifiedView ↗
Trade:
Patel Sanj KCHAIRMAN & CEO · Director
Gift receivedClass A Ordinary ShareNon-derivative security · Code G111,7940Value: 0Currency not specifiedView ↗
Trade:
Paolini John F.CHIEF MEDICAL OFFICER
Exercise / conversionClass A Ordinary ShareNon-derivative security · Code M46,0008.83Value: 406,180Currency not specifiedView ↗
Trade:
Paolini John F.CHIEF MEDICAL OFFICER
Exercise / conversionClass A Ordinary ShareNon-derivative security · Code M36,5423.8Value: 138,859.6Currency not specifiedView ↗
Trade:
Ragosa MarkCHIEF FINANCIAL OFFICER
Exercise / conversionClass A Ordinary ShareNon-derivative security · Code M10030.93Value: 3,093Currency not specifiedView ↗
Trade:
Patel Sanj KCHAIRMAN & CEO · Director
Exercise / conversionClass A Ordinary ShareNon-derivative security · Code M97,3903.8Value: 370,082Currency not specifiedView ↗
Trade:
Patel Sanj KCHAIRMAN & CEO · Director
Exercise / conversionClass A Ordinary ShareNon-derivative security · Code M39,3313.8Value: 149,457.8Currency not specifiedView ↗
Trade:
Patel Sanj KCHAIRMAN & CEO · Director
Exercise / conversionClass A Ordinary ShareNon-derivative security · Code M121,2483.8Value: 460,742.4Currency not specifiedView ↗
Trade:
Megna Michael RCHIEF ACCOUNTING OFFICER
Exercise / conversionClass A Ordinary ShareNon-derivative security · Code M12,78710.76Value: 137,588.12Currency not specifiedView ↗
Trade:
Megna Michael RCHIEF ACCOUNTING OFFICER
Exercise / conversionClass A Ordinary ShareNon-derivative security · Code M9,83111.97Value: 117,677.07Currency not specifiedView ↗
Trade:
Megna Michael RCHIEF ACCOUNTING OFFICER
Exercise / conversionClass A Ordinary ShareNon-derivative security · Code M9,83111.1Value: 109,124.1Currency not specifiedView ↗
Trade:
Megna Michael RCHIEF ACCOUNTING OFFICER
Exercise / conversionClass A Ordinary ShareNon-derivative security · Code M6,19512.97Value: 80,349.15Currency not specifiedView ↗
Trade:
Megna Michael RCHIEF ACCOUNTING OFFICER
Exercise / conversionClass A Ordinary ShareNon-derivative security · Code M79115.5Value: 12,260.5Currency not specifiedView ↗
Trade:
Tessari EbenCHIEF OPERATING OFFICER
Exercise / conversionClass A Ordinary ShareNon-derivative security · Code M6,5008.83Value: 57,395Currency not specifiedView ↗

Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →